MedTrace Logo

Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns

NCT02673229 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-10

Study results available
· View outcomes & findings →

Summary

By doing this study, researchers hope to learn if applying Santyl to the burn during the healing process affects the appearance of the resulting scar.

Conditions

  • Burn, Partial Thickness

Interventions

DRUG

Collagenase Santyl

A sterile, enzymatic debriding agent which contains 250 collagenase units per gram of white petrolatum, United States Pharmacopeia (USP).

DRUG

Bacitracin

One gram is equal to 500 bacitracin units; one unit of bacitracin is equivalent to 0.026 milligrams.

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Principal Investigators

  • Dhaval Bhavsar, MD · University of Kansas Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2018-12-27
Completion
2020-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02673229 on ClinicalTrials.gov